Corestreet Logo

Kala Pharmaceuticals Inc (KALA) Insider Trading

Total insider buys:
  • $112,097,301.57
Total insider sells:
  • $1,892,927.14
Most recent insider trade:
  • Jan. 6, 2025
Most active insider trader:
  • Orbimed Advisors Llc
Trader NameDateTitleAmountPriceTypeTotal Value
Jan. 6, 2025Insider2,021$7.63Sell$15,420.23
Jan. 6, 2025CFO1,706$7.63Sell$13,016.78
Jan. 6, 2025CEO5,779$7.63Sell$44,093.77
Dec. 30, 2024Major Shareholder310,559$6.44Buy$1,999,999.96
June 26, 2024Insider4,653$4.75Sell$22,101.75
June 26, 2024CEO15,168$4.75Sell$72,048.00
June 26, 2024CFO4,163$4.75Sell$19,774.25
May 31, 2024CFO1,786$6.09Sell$10,876.74
May 31, 2024Insider2,093$6.09Sell$12,746.37
May 31, 2024CEO7,392$6.09Sell$45,017.28
Jan. 4, 2024CEO4,539$6.73Sell$30,547.47
Jan. 4, 2024Insider1,227$6.74Sell$8,269.98
Jan. 4, 2023Insider60$28.55Sell$1,713.00
Jan. 4, 2023CEO198$28.54Sell$5,650.92
Oct. 26, 2022Insider194$6.52Sell$1,264.88
Oct. 26, 2022CEO561$6.52Sell$3,657.72
June 27, 2022CEO7,975$0.37Sell$2,950.75
June 27, 2022Insider2,613$0.37Sell$966.81
May 25, 2022Major Shareholder1,434,509$0.42Sell$602,493.78
May 23, 2022Major Shareholder1,250,000$0.65Sell$812,500.00
Jan. 4, 2022CFO2,850$1.30Sell$3,705.00
Jan. 4, 2022Insider3,504$1.30Sell$4,555.20
Jan. 4, 2022CEO9,518$1.30Sell$12,373.40
Oct. 26, 2021CEO27,598$1.80Sell$49,676.40
Oct. 26, 2021Insider9,449$1.80Sell$17,008.20
Oct. 26, 2021COO12,544$1.80Sell$22,579.20
June 28, 2021Insider2,452$5.77Sell$14,148.04
June 28, 2021CEO7,586$5.77Sell$43,771.22
Oct. 22, 2020COO40$7.60Buy$304.00
June 5, 2020COO2$13.39Buy$26.78
March 16, 2020COO10,000$5.75Buy$57,500.00
March 13, 2020Director6,337,135$7.89Buy$49,999,995.15
May 30, 2019Director5,000$5.42Buy$27,100.00
Oct. 5, 2018Director606,060$8.25Buy$4,999,995.00
Oct. 3, 2018Director2,424,242$8.25Buy$19,999,996.50
Feb. 8, 2018Major Shareholder25,000$12.93Buy$323,250.00
Feb. 1, 2018Major Shareholder362,240$15.00Buy$5,433,600.00
Jan. 29, 2018Major Shareholder72,760$14.97Buy$1,089,217.20
Jan. 26, 2018Major Shareholder22,760$14.93Buy$339,806.80
Jan. 24, 2018Major Shareholder64,637$14.91Buy$963,737.67
Jan. 22, 2018Major Shareholder75,000$14.98Buy$1,123,500.00
Jan. 19, 2018Major Shareholder74,931$14.95Buy$1,120,218.45
Jan. 12, 2018Major Shareholder240,484$13.28Buy$3,193,627.52
Jan. 10, 2018Major Shareholder170,338$12.83Buy$2,185,436.54
July 25, 2017Insider319,333$15.00Buy$4,789,995.00
July 25, 2017Major Shareholder215,000$15.00Buy$3,225,000.00
July 25, 2017Director533,333$15.00Buy$7,999,995.00
July 20, 2017Major Shareholder215,000$15.00Buy$3,225,000.00
First«1 of 1»Last

  • Insiders are both buying and selling Kala Pharmaceuticals Inc stock.

  • The insider traders at Kala Pharmaceuticals Inc are: Orbimed Advisors Llc, Mark T Iwicki, Todd Bazemore, Eric Trachtenberg, Mary Reumuth, Rajeev M Shah, Ra Capital Management, L.P., Hongming Chen, Darius Kharabi, Mark T. Iwicki, Associates L.L.C. Cdk, Bros. Advisors Lp Baker, Ra Capital Healthcare Fund Lp, Romulus K Brazzell, Gregory Grunberg, Howard B Rosen, and Longitude Capital Partners Ii,

  • The most active insider trader at Kala Pharmaceuticals Inc is Orbimed Advisors Llc with 10 trades.

  • Ra Capital Management, L.P. has sold the most Kala Pharmaceuticals Inc stock with a total value of $2,017,487.56.

  • Rajeev M Shah has bought the most Kala Pharmaceuticals Inc stock with a total value of $107,999,985.30.

  • The most recent insider trade for Kala Pharmaceuticals Inc was on Jan. 6, 2025.

  • The single biggest insider buy for Kala Pharmaceuticals Inc was from Rajeev M Shah with a total value of $49,999,995.15 on March 13, 2020.

  • The single biggest insider sell for Kala Pharmaceuticals Inc was from Ra Capital Management, L.P. with a total value of $812,500.00 on May 23, 2022.